Dextrifyl (filgrastim biosimilar)
/ PiSA Farmaceutica
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 06, 2019
Efficacy of three filgrastim-intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico.
(PubMed, J Clin Apher)
- "In conclusion, three FICs available in Mexico were efficacious and without immediate severe adverse effects, resulting in significant cost savings. Evaluation of immunogenicity and establishment of a pharmacovigilance program with the use of FICs is warranted."
Clinical • Journal
1 to 1
Of
1
Go to page
1